MOSCOW, Feb 4 (Reuters) - Human trials of a vaccine
combining the shot developed by Britain's AstraZeneca
and Oxford University and Russia's Sputnik V shot will begin
next week in Azerbaijan and some Middle East countries, a
Russian official said on Thursday.
The first results of the joint trials are expected in March,
the head of Russia's RDIF sovereign wealth fund, Kirill
Dmitriev, said.
The RDIF fund is also going to announce joint trials of the
Russian vaccine with a large Chinese company, Dmitriev said.
(Reporting by Polina Nikolskaya; Editing by Jon Boyle)
Astrazeneca (AZN)
